Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies

This publication has 28 references indexed in Scilit:

• Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.
  Journal of Clinical Oncology, 1987
• Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indium
  European Journal of Nuclear Medicine and Molecular Imaging, 1985
• Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience
  Cancer, 1985
• Requirements for a treatment planning system for radioimmunotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1985
• Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies
  British Journal of Cancer, 1982
• Long-Term Follow-Up and Prognostic Factors in Ovarian Carcinoma: The Radiumhemmet series 1958 to 1973
  Acta Radiologica: Oncology, 1982
• Radioactive chromic phosphate suspension: Studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients
  Gynecologic Oncology, 1981
• Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers
  International Journal of Cancer, 1981
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
  Biochemical and Biophysical Research Communications, 1978
• THE STUDY AND TREATMENT OF 119 CASES OF CARCINOMA OF THE THYROID WITH RADIOACTIVE IODINE*†
  Journal of Clinical Endocrinology & Metabolism, 1951